Houlihan Lokey, Inc.
HLI
$157.47
$0.140.09%
Weiss Ratings | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Fair | |||
Risk Grade | C+ | |||
Reward Grade | C+ | |||
Rating Factors | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Fair | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.12 | |||
Price History | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -7.47% | |||
30-Day Total Return | -15.32% | |||
60-Day Total Return | -14.27% | |||
90-Day Total Return | -6.01% | |||
Year to Date Total Return | -7.92% | |||
1-Year Total Return | 28.30% | |||
2-Year Total Return | 75.19% | |||
3-Year Total Return | 70.68% | |||
5-Year Total Return | 257.78% | |||
52-Week High % Change | -18.10% | |||
52-Week Low % Change | 29.16% | |||
Price | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $192.10 | |||
52-Week Low Price | $121.81 | |||
52-Week Low Price (Date) | Mar 20, 2024 | |||
52-Week High Price (Date) | Nov 25, 2024 | |||
Valuation | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 11.04B | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | 29.99 | |||
Earnings Per Share (TTM) | 5.25 | |||
Earnings Per Share Growth | 37.83% | |||
Price/Earnings To Growth | 0.79 | |||
Price/Sales (TTM) | 4.82 | |||
Price/Book (Q) | 5.30 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $157.47 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 68.76M | |||
Dividend Yield | 1.45% | |||
Div. Per Share (Most Recent) | $0.57 | |||
Dividend Per Share (TTM) | $2.28 | |||
Payout Ratio (TTM) | 45.21% | |||
Dividend Per Share (Most Recent) | $0.57 | |||
Company Info | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 310 553 8871 | |||
Address | 10250 Constellation Boulevard Los Angeles, CA 90067 | |||
Website | hl.com | |||
Country | United States | |||
Year Founded | 1972 | |||
Profitability | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 21.50% | |||
Profit Margin | 15.99% | |||
Management Effectiveness | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | 18.64% | |||
Income Statement | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 2.24B | |||
Total Revenue (TTM) | 2.24B | |||
Revenue Per Share | $32.62 | |||
Gross Profit (TTM) | 2.11B | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | 358.87M | |||
Net Income Avl. to Common (TTM) | 358.87M | |||
Total Revenue Growth (Q YOY) | 24.11% | |||
Earnings Growth (Q YOY) | 34.60% | |||
EPS Diluted (TTM) | 5.25 | |||
EPS Diluted Growth (Q YOY) | 33.65% | |||
Balance Sheet | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 799.34M | |||
Cash Per Share (Q) | $11.62 | |||
Total Current Assets (Q) | 1.21B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.08B | |||
Current Ratio (Q) | 1.355 | |||
Book Value Per Share (Q) | $29.66 | |||
Total Assets (Q) | 3.48B | |||
Total Current Liabilities (Q) | 895.76M | |||
Total Debt (Q) | 433.03M | |||
Total Liabilities (Q) | 1.40B | |||
Total Common Equity (Q) | 2.08B | |||
Cash Flow | HLI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -173.40M | |||
Cash from Financing (TTM) | -274.13M | |||
Net Change in Cash (TTM) | 244.89M | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | 715.54M | |||